Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003911 · ClinicalTrials.gov registry record · Phase 4
Azithromycin for Children Hospitalized With Asthma
A Phase 4 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 159
- Enrollment target
NCT02003911 is a Phase 4 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 159 participants.
The verdict
NCT02003911, a Phase 4 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 159 participants
- Enrollment target
Study Summary
Asthma is a chronic lung condition in children, and often requires hospitalization for acute exacerbations. Azithromycin has been used successfully in other chronic lung diseases, including cystic fibrosis. Despite limited clinical evidence, some pediatricians use azithromycin in children hospitalized with asthma, citing either treatment of atypical pathogens or its proposed anti-inflammatory properties. This study proposes a clinical trial to determine if azithromycin will shorten length of stay in children hospitalized with acute asthma exacerbations.
Interventions
- DRUG Placebo
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02003911
The ClinicalTrials.gov registry entry for NCT02003911 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02003911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02003911 about?
NCT02003911 is a clinical study titled "Azithromycin for Children Hospitalized With Asthma". Asthma is a chronic lung condition in children, and often requires hospitalization for acute exacerbations. Azithromycin has been used successfully in other chronic lung diseases, including cystic fibrosis. Despite limited clinical evidence, some pediatricians use azithromycin in children hospitaliz...
What is the current status of trial NCT02003911?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 159 participants. The study started on 2013-10. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT02003911?
The interventions under investigation include: Placebo (DRUG), Azithromycin (DRUG).
Who is sponsoring clinical trial NCT02003911?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.